IntrinsicIntrinsic
← All summaries

First Seacoast Bancorp, Inc.

FSEA
Financials & Chart →

Business Summary

First Seacoast Bancorp, Inc. (the "Company") operates as a savings and loan holding company, conducting its primary operations through its wholly-owned subsidiary, First Seacoast Bank (the "Bank"). The Bank, headquartered in Dover, New Hampshire, has been serving the Seacoast area of New Hampshire since 1890. Its business model primarily involves attracting deposits from the general public and investing these funds, along with capital from operations and Federal Home Loan Bank borrowings, into various loan types and investment securities. The Company's results are largely driven by net interest income, which is the spread between interest earned on assets and interest paid on liabilities, supplemented by non-interest income from customer service fees. The Company also offers investment management services through FSB Wealth Management, a division of First Seacoast Bank, which provides access to non-FDIC insured products like retirement planning, portfolio management, and investment/insurance strategies through a third-party broker-dealer and investment advisor.

The Company generates revenue through a mix of interest income from its loan and securities portfolios and non-interest income. Interest income on loans and securities forms the core, while interest expense on deposits and borrowings is a significant cost. Non-interest income is largely derived from customer service fees, gains on loan sales, and investment services fees from FSB Wealth Management. The primary customer segments are individuals and businesses within its market area, encompassing Strafford and Rockingham Counties in New Hampshire and York County in southern Maine. The Company emphasizes developing comprehensive banking relationships, particularly with commercial borrowers, by requiring them to maintain primary deposit accounts with the Bank.

The Bank's lending activities are diversified, though historically focused on one- to four-family residential real estate loans. At December 31, 2025, one- to four-family residential real estate loans constituted $265.2 million or 63.2% of the total loan portfolio. Commercial real estate and multi-family real estate loans totaled $85.4 million (20.4% of the portfolio), with $56.8 million in owner-occupied commercial real estate, $23.8 million in non-owner-occupied commercial real estate, and $4.8 million in multi-family real estate loans. Acquisition, development, and land loans were $12.9 million (3.1% ), and commercial and industrial loans were $22.5 million (5.4% ). Home equity loans and lines of credit amounted to $20.7 million (4.9% ), and consumer loans were $12.7 million (3.0% ). The Company aims to diversify its loan portfolio towards higher-yielding commercial real estate and commercial and industrial loans.

Investment activities are guided by a policy focused on liquidity, interest rate and market risk mitigation, asset diversification, and generating a reasonable return. All investment securities are classified as available-for-sale. At December 31, 2025, the securities portfolio of $152.4 million included U.S. Government-sponsored enterprises obligations of $1.5 million (1.0% of the portfolio), U.S. Government agency small business administration pools of $10.6 million (6.9% ), municipal bonds of $29.3 million (19.2% ), U.S. Government-sponsored mortgage-backed securities of $99.2 million (65.1% ), corporate debt of $6.2 million (4.1% ), and corporate subordinated debt of $5.7 million (3.7% ).

For the year ended December 31, 2025, the Company reported a net loss of $845,000 , an increase from the net loss of $513,000 in 2024. Total assets increased by $18.5 million to $599.3 million at December 31, 2025, from $580.8 million at December 31, 2024. Total loans decreased by $19.4 million to $419.5 million from $439.0 million . Total deposits increased by $16.6 million to $470.8 million from $454.2 million . Total borrowings remained stable at $52.3 million for both periods. Stockholders' equity increased by $1.5 million to $63.5 million from $62.1 million . Basic and diluted loss per share were both $(0.23) for 2025, compared to $(0.12) for 2024.

Year-over-year, net interest and dividend income increased by $1.8 million , or 15.0% , to $13.7 million in 2025 from $11.9 million in 2024. This was driven by a $1.6 million increase in interest and dividend income, partially offset by a $234,000 decrease in interest expense. Non-interest income decreased significantly by $2.2 million , or 55.1% , to $1.8 million in 2025 from $3.9 million in 2024, primarily due to a one-time $2.5 million gain on the sale of land and buildings in 2024. Non-interest expense increased by $1.1 million , or 6.7% , to $16.9 million in 2025 from $15.9 million in 2024. The Company recorded an income tax benefit of $638,000 in 2025, a substantial change from the $527,000 income tax expense in 2024.

Significant operational developments during the period include the completion of a balance sheet repositioning strategy on December 11, 2024, involving the sale of $23.5 million in lower-yielding investment securities for an after-tax realized gain of $5,000 and the purchase of $16.6 million of higher-yielding investment securities. On November 28, 2023, a similar strategy involved selling $40.6 million in investment securities for an after-tax realized loss of $3.1 million and purchasing $40.6 million of higher-yielding securities. The Bank also completed a sale-leaseback transaction on June 11, 2024, for four properties, generating a pre-tax gain of $2.5 million . The Company purchased $3.6 million and $1.9 million of participation interests in commercial and industrial loans and consumer loans secured by manufactured housing properties, respectively, during 2025.

Business Outlook

The Company's business strategy remains consistent, focusing on growing its balance sheet, leveraging existing infrastructure, and improving profitability and operating efficiency without a proportional increase in overhead or operating risk. Management believes it is well-positioned for growth due to an experienced team and established departments for marketing, IT, audit, and compliance, alongside investments in Internet and mobile banking.

A key growth area is the expansion of the loan portfolio, particularly in higher-yielding commercial real estate and commercial and industrial loans. While maintaining its role as a residential mortgage lender, the Company intends to increase its focus on these commercial segments to improve net margins and manage interest rate risk. The increased legal lending limit supports originating larger loans for its portfolio, reducing the need for participations with other lenders.

The Company also plans to increase core deposits and reduce reliance on higher-cost borrowings. Core deposits, defined as all deposits excluding time deposits, represented 67.7% of total deposits at December 31, 2025. The strategy involves expanding core deposits by leveraging business development officers and commercial lending and retail relationships. At December 31, 2025, the ratio of net loans to deposits was 88.4% , and borrowings from supplemental funding sources totaled $52.3 million .

Operationally, the Company aims to maintain strong asset quality and manage credit risk, attributing its historical credit quality to a conservative credit culture, effective credit risk management, experienced credit professionals, well-defined policies, conservative underwriting, and active credit monitoring. The ratio of non-performing assets as a percent of total assets was 0.08% at December 31, 2025.

The Company's capital allocation plans include using its capital to increase lending and investment capacity, primarily through organic growth. It may also consider opportunistic expansion through acquisitions or de novo branching in its market area or contiguous markets to enhance franchise value and stockholder returns, though no current plans for such expansion are in place. The board of directors authorized a stock repurchase program on April 11, 2024, for up to 507,707 shares, with an additional authorization of up to 228,858 shares on December 12, 2024. As of December 31, 2025, 494,379 shares have been repurchased under this program, which was extended to June 3, 2026 .

Risk Factors

The Company faces several material risks. General economic conditions, both nationally and in its market areas, can be worse than expected, impacting loan delinquencies, write-offs, and the adequacy of the allowance for credit losses. Fluctuations in real estate values and market conditions for both residential and commercial properties pose a risk. The Company's ability to access cost-effective funding is crucial, and competition from various financial institutions, including those with greater resources and broader product offerings, is substantial. Inflation and changes in the interest rate environment can reduce margins and yields, mortgage banking revenues, the fair value of financial instruments, or the level of loan originations or prepayments. Adverse changes in the securities or secondary mortgage markets are also a concern. Regulatory changes, including those affecting fees, capital requirements, and insurance premiums, could negatively impact operations. Technological changes may be more difficult or expensive than anticipated, and the inability of third-party providers to perform as expected is a risk. The Company must effectively manage market risk, credit risk, and operational risk, including cybersecurity risks and artificial intelligence (AI) risks. Its economic value of equity analysis as of December 31, 2025, estimated that an instantaneous 200 basis point increase in interest rates would result in a 22.8% decrease in economic value of equity, which was above the policy limit of 20.0% .

Management Priorities

Management's message to shareholders emphasizes a commitment to a safe and sound, service-oriented business strategy aimed at producing increasing earnings that can be reinvested in the business and communities. Key strategic priorities include growing the balance sheet, leveraging existing infrastructure, and improving profitability and operating efficiency. Management intends to grow the loan portfolio by increasing commercial real estate and commercial and industrial lending, while maintaining strong asset quality and managing credit risk. Another priority is to increase core deposits and reduce reliance on higher-cost borrowings. The Company also plans for organic growth and may consider opportunistic acquisitions or de novo branching. The board of directors authorized a stock repurchase program for up to 507,707 shares on April 11, 2024, with an additional authorization of up to 228,858 shares on December 12, 2024, and the program's expiration date was extended to June 3, 2026 .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Loan Portfolio Composition
  2. [2] Item 1, Business — Loan Portfolio Composition
  3. [3] Item 1, Business — Loan Portfolio Composition
  4. [4] Item 1, Business — Loan Portfolio Composition
  5. [5] Item 1, Business — Loan Portfolio Composition
  6. [6] Item 1, Business — Commercial Real Estate and Multi-Family Real Estate Loans
  7. [7] Item 1, Business — Commercial Real Estate and Multi-Family Real Estate Loans
  8. [8] Item 1, Business — Commercial Real Estate and Multi-Family Real Estate Loans
  9. [9] Item 1, Business — Commercial Real Estate and Multi-Family Real Estate Loans
  10. [10] Item 1, Business — Commercial Real Estate and Multi-Family Real Estate Loans
  11. [11] Item 1, Business — Acquisition, Development and Land Loans
  12. [12] Item 1, Business — Acquisition, Development and Land Loans
  13. [13] Item 1, Business — Commercial and Industrial Loans
  14. [14] Item 1, Business — Commercial and Industrial Loans
  15. [15] Item 1, Business — Home Equity Loans and Lines of Credit
  16. [16] Item 1, Business — Home Equity Loans and Lines of Credit
  17. [17] Item 1, Business — Consumer Loans
  18. [18] Item 1, Business — Consumer Loans
  19. [19] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Available-for-Sale Securities
  20. [20] Item 1, Business — U.S. Government-Sponsored Enterprises Obligations
  21. [21] Item 1, Business — U.S. Government-Sponsored Enterprises Obligations
  22. [22] Item 1, Business — U.S. Government Agency Small Business Administration Pools
  23. [23] Item 1, Business — U.S. Government Agency Small Business Administration Pools
  24. [24] Item 1, Business — Municipal Bonds
  25. [25] Item 1, Business — Municipal Bonds
  26. [26] Item 1, Business — U.S. Government-Sponsored Mortgage-Backed Securities
  27. [27] Item 1, Business — U.S. Government-Sponsored Mortgage-Backed Securities
  28. [28] Item 1, Business — Corporate Debt
  29. [29] Item 1, Business — Corporate Debt
  30. [30] Item 1, Business — Corporate Subordinated Debt
  31. [31] Item 1, Business — Corporate Subordinated Debt
  32. [32] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Net Loss
  33. [33] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Net Loss
  34. [34] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Total Assets
  35. [35] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Total Assets
  36. [36] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Total Assets
  37. [37] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Net Loans
  38. [38] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Net Loans
  39. [39] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Net Loans
  40. [40] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Deposits
  41. [41] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Deposits
  42. [42] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Deposits
  43. [43] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Borrowings
  44. [44] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Total Stockholders’ Equity
  45. [45] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Total Stockholders’ Equity
  46. [46] Item 7, MD&A — Comparison of Financial Condition at December 31, 2025 and December 31, 2024 — Total Stockholders’ Equity
  47. [47] Item 7, MD&A — Selected Financial Data
  48. [48] Item 7, MD&A — Selected Financial Data
  49. [49] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Net Interest and Dividend Income
  50. [50] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Net Interest and Dividend Income
  51. [51] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Net Interest and Dividend Income
  52. [52] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Net Interest and Dividend Income
  53. [53] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Interest and Dividend Income
  54. [54] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Interest Expense
  55. [55] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Income
  56. [56] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Income
  57. [57] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Income
  58. [58] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Income
  59. [59] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Income
  60. [60] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Expense
  61. [61] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Expense
  62. [62] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Expense
  63. [63] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Non-Interest Expense
  64. [64] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Income Taxes
  65. [65] Item 7, MD&A — Comparison of Operating Results for the Years Ended December 31, 2025 and 2024 — Income Taxes
  66. [66] Item 1, Business — Accumulated Other Comprehensive Loss and Available-for-Sale Securities
  67. [67] Item 1, Business — Accumulated Other Comprehensive Loss and Available-for-Sale Securities
  68. [68] Item 1, Business — Accumulated Other Comprehensive Loss and Available-for-Sale Securities
  69. [69] Item 1, Business — Accumulated Other Comprehensive Loss and Available-for-Sale Securities
  70. [70] Item 1, Business — Accumulated Other Comprehensive Loss and Available-for-Sale Securities
  71. [71] Item 1, Business — Accumulated Other Comprehensive Loss and Available-for-Sale Securities
  72. [72] Item 2, Properties
  73. [73] Item 1, Business — Commercial and Industrial Loans
  74. [74] Item 1, Business — Consumer Loans
  75. [75] Item 7, MD&A — Business Strategy
  76. [76] Item 7, MD&A — Business Strategy
  77. [77] Item 7, MD&A — Business Strategy
  78. [78] Item 7, MD&A — Business Strategy
  79. [79] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  80. [80] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  81. [81] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  82. [82] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  83. [83] Item 7, MD&A — Management of Market Risk — Economic Value of Equity
  84. [84] Item 7, MD&A — Management of Market Risk — Economic Value of Equity
  85. [85] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  86. [86] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  87. [87] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Analysis on 5/22/2026